|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
multiple interactions |
EXP |
Silybin affects the localization of and affects the activity of ABCB11 protein |
CTD |
PMID:15763547 |
|
NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
Silybin inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; Silybin promotes the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]] |
CTD |
PMID:34217736 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
multiple interactions increases phosphorylation |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased phosphorylation of ACACA protein] Silybin results in increased phosphorylation of ACACA protein |
CTD |
PMID:25294820 PMID:25559859 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Acly |
ATP citrate lyase |
decreases phosphorylation |
ISO |
Silybin results in decreased phosphorylation of ACLY protein |
CTD |
PMID:25294820 |
|
NCBI chr10:85,412,045...85,464,253
Ensembl chr10:85,412,049...85,463,320
|
|
G |
Adipor2 |
adiponectin receptor 2 |
increases expression |
EXP |
silymarin (silibinin) increases expression of adipor2 mRNA and protein in epididymal white adipose tissue of alcohol fed rats |
RGD |
PMID:26115886 |
RGD:25330099 |
NCBI chr 4:152,524,604...152,588,848
Ensembl chr 4:152,524,623...152,559,355
|
|
G |
Agpat3 |
1-acylglycerol-3-phosphate O-acyltransferase 3 |
multiple interactions |
EXP |
Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in increased expression of AGPAT3 mRNA] |
CTD |
PMID:28619387 |
|
NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
decreases activity |
ISO |
Silybin results in decreased activity of AKR1C3 protein |
CTD |
PMID:19007764 |
|
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:25559859 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
decreases expression |
ISO |
Silybin results in decreased expression of AMACR protein |
CTD |
PMID:25294820 |
|
NCBI chr 2:59,946,158...59,958,255
Ensembl chr 2:59,946,153...59,958,255
|
|
G |
Apoa5 |
apolipoprotein A5 |
multiple interactions |
EXP |
Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of APOA5 mRNA] |
CTD |
PMID:28619387 |
|
NCBI chr 8:46,561,180...46,563,818
Ensembl chr 8:46,561,229...46,563,816
|
|
G |
Asl |
argininosuccinate lyase |
multiple interactions |
EXP |
Silybin inhibits the reaction [[Isoniazid co-treated with Zidovudine] results in increased activity of ASL protein] |
CTD |
PMID:28619387 |
|
NCBI chr12:26,659,664...26,677,136
Ensembl chr12:26,659,565...26,679,662
|
|
G |
Atm |
ATM serine/threonine kinase |
multiple interactions |
ISO |
Silybin results in increased phosphorylation of and results in increased activity of ATM protein |
CTD |
PMID:16777994 |
|
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in increased expression of BAX protein]; Silybin inhibits the reaction [Ethanol results in increased expression of BAX protein]; Silybin inhibits the reaction [Mitomycin affects the localization of BAX protein]; Silybin inhibits the reaction [Staurosporine promotes the reaction [Acetaldehyde results in increased expression of BAX protein]] |
CTD |
PMID:19834285 PMID:35158046 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO |
Silybin results in decreased expression of BCL2 mRNA [Silybin co-treated with Arsenic Trioxide] results in decreased expression of BCL2 mRNA; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of BCL2 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]; Silybin inhibits the reaction [Mitomycin affects the expression of BCL2]; Silybin inhibits the reaction [Staurosporine promotes the reaction [Acetaldehyde results in decreased expression of BCL2 protein]] |
CTD |
PMID:19834285 PMID:21969006 PMID:35158046 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bid |
BH3 interacting domain death agonist |
multiple interactions increases cleavage affects localization |
ISO |
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Silybin results in increased cleavage of BID protein]; Caffeine inhibits the reaction [Silybin results in increased cleavage of BID protein]; pifithrin inhibits the reaction [Silybin results in increased cleavage of BID protein] Silybin affects the localization of BID protein modified form |
CTD |
PMID:16777994 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
multiple interactions |
ISO |
[Silybin co-treated with Arsenic Trioxide] results in decreased expression of BIRC5 mRNA |
CTD |
PMID:21969006 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Car9 |
carbonic anhydrase 9 |
decreases expression multiple interactions |
ISO |
Silybin results in decreased expression of CA9 mRNA Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA] |
CTD |
PMID:21969006 |
|
NCBI chr 5:57,763,234...57,769,838
Ensembl chr 5:57,763,206...57,769,838
|
|
G |
Casp2 |
caspase 2 |
multiple interactions |
ISO |
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP2 protein]; Caffeine inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP2 protein]; pifithrin inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP2 protein]; Silybin results in increased cleavage of and results in increased activity of CASP2 protein |
CTD |
PMID:16777994 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions increases activity |
ISO |
Silybin results in increased expression of CASP3 mRNA Arsenic Trioxide promotes the reaction [Silybin results in increased activity of CASP3 protein]; benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP3 protein]; Caffeine inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP3 protein]; pifithrin inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP3 protein]; Silybin inhibits the reaction [Acetaldehyde results in increased cleavage of CASP3 protein]; Silybin inhibits the reaction [Ethanol results in increased cleavage of CASP3 protein]; Silybin promotes the reaction [Arsenic Trioxide results in increased expression of CASP3 mRNA]; Silybin results in increased cleavage of and results in increased activity of CASP3 protein |
CTD |
PMID:16777994 PMID:21969006 PMID:35158046 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP8 protein]; pifithrin inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP8 protein]; Silybin results in increased cleavage of and results in increased activity of CASP8 protein |
CTD |
PMID:16777994 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP9 protein]; Caffeine inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP9 protein]; pifithrin inhibits the reaction [Silybin results in increased cleavage of and results in increased activity of CASP9 protein]; Silybin results in increased cleavage of and results in increased activity of CASP9 protein |
CTD |
PMID:16777994 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
EXP |
Silybin inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased activity of CAT protein]; Silybin inhibits the reaction [Arsenic results in decreased activity of CAT protein] |
CTD |
PMID:22229868 PMID:35752206 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCNA2 protein] |
CTD |
PMID:25559859 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnb1 |
cyclin B1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Arsenic results in increased expression of CCNB1] |
CTD |
PMID:25868784 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CCND1 protein] Silybin results in decreased expression of CCND1 protein [Silybin co-treated with Arsenic] results in decreased expression of CCND1 protein |
CTD |
PMID:16788158 PMID:25559859 PMID:25868784 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccnd3 |
cyclin D3 |
multiple interactions |
ISO |
[Silybin co-treated with Arsenic] results in decreased expression of CCND3 protein |
CTD |
PMID:25868784 |
|
NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Arsenic results in increased expression of CDK1 protein] |
CTD |
PMID:25868784 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdk2 |
cyclin dependent kinase 2 |
multiple interactions |
ISO |
[Silybin co-treated with Arsenic] results in decreased expression of CDK2 protein |
CTD |
PMID:25868784 |
|
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
multiple interactions |
ISO |
[Silybin co-treated with Arsenic] results in decreased expression of CDK4 protein |
CTD |
PMID:25868784 |
|
NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403
|
|
G |
Cdk6 |
cyclin-dependent kinase 6 |
multiple interactions |
ISO |
[Silybin co-treated with Arsenic] results in decreased expression of CDK6 protein |
CTD |
PMID:25868784 |
|
NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions increases cleavage |
ISO |
[Silybin co-treated with Arsenic] results in increased expression of CDKN1A protein; benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [Silybin results in increased cleavage of CDKN1A protein] |
CTD |
PMID:16777994 PMID:25868784 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein] [Silybin co-treated with Arsenic] results in increased expression of CDKN1B protein |
CTD |
PMID:25559859 PMID:25868784 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] |
CTD |
PMID:25559859 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Chek2 |
checkpoint kinase 2 |
increases phosphorylation multiple interactions |
ISO |
Silybin results in increased phosphorylation of CHEK2 protein Caffeine inhibits the reaction [Silybin results in increased phosphorylation of CHEK2 protein] |
CTD |
PMID:16777994 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
[Silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A1 mRNA] |
CTD |
PMID:16169303 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
ISO |
[Arsenic Trioxide co-treated with Silybin] results in decreased expression of CTSB mRNA |
CTD |
PMID:21969006 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Cyb5a |
cytochrome b5 type A |
multiple interactions |
EXP |
Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of CYB5A mRNA] |
CTD |
PMID:28619387 |
|
NCBI chr18:78,213,067...78,245,677
Ensembl chr18:78,202,342...78,258,535 Ensembl chr18:78,202,342...78,258,535
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
Silybin inhibits the reaction [sodium arsenite results in increased expression of CYBB] |
CTD |
PMID:24062023 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
decreases activity |
ISO |
Silybin results in decreased activity of CYP2C8 protein |
CTD |
PMID:28457856 |
|
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions decreases activity |
ISO |
Silybin inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone] Silybin results in decreased activity of CYP3A4 protein |
CTD |
PMID:15155549 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions |
ISO |
DDIT3 affects the reaction [Silybin results in increased expression of TNFRSF10B] |
CTD |
PMID:19939880 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of DLK1 mRNA] |
CTD |
PMID:25559859 |
|
NCBI chr 6:128,410,216...128,417,518
Ensembl chr 6:128,410,316...128,417,522
|
|
G |
Dnm1l |
dynamin 1-like |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in increased expression of DNM1L protein]; Silybin inhibits the reaction [Ethanol results in increased expression of DNM1L protein] |
CTD |
PMID:35158046 |
|
NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482
|
|
G |
Egr1 |
early growth response 1 |
increases expression multiple interactions |
ISO |
Silybin results in increased expression of EGR1 protein EGR1 mutant form inhibits the reaction [Silybin results in increased expression of GDF15 protein] |
CTD |
PMID:24440808 |
|
NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
EXP ISO |
Silybin results in increased activity of [ESR1 protein binds to ESR2 protein] |
CTD |
PMID:16076518 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO EXP |
Silybin results in increased activity of [ESR1 protein binds to ESR2 protein] |
CTD |
PMID:16076518 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FABP4 protein] |
CTD |
PMID:25559859 |
|
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Fasn |
fatty acid synthase |
multiple interactions decreases expression |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of FASN protein] Silybin results in decreased expression of FASN protein |
CTD |
PMID:25294820 PMID:25559859 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Urethane results in increased secretion of FGF2 protein] |
CTD |
PMID:16788158 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fth1 |
ferritin heavy chain 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in decreased expression of FTH1 mRNA]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of FTH1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of FTH1 mRNA]; Silybin inhibits the reaction [Ethanol results in decreased expression of FTH1 protein] |
CTD |
PMID:35595033 |
|
NCBI chr 1:206,627,142...206,629,430
Ensembl chr 1:206,627,103...206,725,424
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
multiple interactions |
EXP |
Silybin inhibits the reaction [Arsenic results in decreased activity of G6PD protein] |
CTD |
PMID:22229868 |
|
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
|
|
G |
Gdf15 |
growth differentiation factor 15 |
increases expression multiple interactions |
ISO |
Silybin results in increased expression of GDF15 mRNA; Silybin results in increased expression of GDF15 protein EGR1 mutant form inhibits the reaction [Silybin results in increased expression of GDF15 protein]; GDF15 mutant form inhibits the reaction [Silybin results in increased cleavage of PARP1 protein]; pyrazolanthrone promotes the reaction [Silybin results in increased expression of GDF15 protein]; SB 203580 inhibits the reaction [Silybin results in increased expression of GDF15 protein] |
CTD |
PMID:24440808 |
|
NCBI chr16:18,805,312...18,807,893
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP ISO |
Silybin inhibits the reaction [Isoniazid promotes the reaction [Zidovudine results in increased activity of GPT protein]] Silybin inhibits the reaction [Acetaldehyde results in increased activity of GPT protein]; Silybin inhibits the reaction [Ethanol results in increased activity of and results in increased secretion of GPT protein] |
CTD |
PMID:28619387 PMID:35158046 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
Silybin inhibits the reaction [Arsenic results in decreased activity of GSR protein] |
CTD |
PMID:22229868 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
H2ax |
H2A.X variant histone |
multiple interactions increases phosphorylation |
ISO |
Caffeine inhibits the reaction [Silybin results in increased phosphorylation of H2AX protein] |
CTD |
PMID:16777994 |
|
NCBI chr 8:44,671,927...44,673,257
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
decreases expression |
ISO |
Silybin results in decreased expression of HMGCR protein |
CTD |
PMID:25294820 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
Silybin inhibits the reaction [sodium arsenite results in decreased expression of HMOX1] |
CTD |
PMID:24062023 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
ISO |
Silybin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1A protein] |
CTD |
PMID:33839235 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein] |
CTD |
PMID:33839235 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
multiple interactions |
ISO |
silibinin decreases expression and phosphorylation of JAK2 protein in breast epithelium |
RGD |
PMID:28440514 |
RGD:149735360 |
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions |
EXP |
Silybin inhibits the reaction [sodium arsenite results in increased expression of KEAP1] |
CTD |
PMID:24062023 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Klf2 |
KLF transcription factor 2 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of KLF2 mRNA] |
CTD |
PMID:25559859 |
|
NCBI chr16:17,521,773...17,523,723
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF4 mRNA] silibinin inhibits the reaction [angiotensin II increases expression of KLF4 protein in vascular smooth muscle cells] |
CTD RGD |
PMID:25559859 PMID:29127880 |
RGD:155230825 |
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Klf5 |
KLF transcription factor 5 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of KLF5 mRNA] |
CTD |
PMID:25559859 |
|
NCBI chr15:76,060,320...76,079,445
Ensembl chr15:76,064,258...76,079,445
|
|
G |
Lpin1 |
lipin 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of LPIN1 protein] |
CTD |
PMID:25559859 |
|
NCBI chr 6:39,309,198...39,417,034
Ensembl chr 6:39,312,748...39,417,097
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:25559859 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:25559859 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases phosphorylation multiple interactions |
ISO |
Silybin results in increased phosphorylation of MAPK8 protein pifithrin inhibits the reaction [Silybin results in increased phosphorylation of MAPK8 protein]; pyrazolanthrone inhibits the reaction [Silybin results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:16777994 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
multiple interactions increases phosphorylation |
ISO |
pifithrin inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein]; pyrazolanthrone inhibits the reaction [Silybin results in increased phosphorylation of MAPK9 protein] |
CTD |
PMID:16777994 |
|
NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178
|
|
G |
Mfn1 |
mitofusin 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in decreased expression of MFN1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of MFN1 protein] |
CTD |
PMID:35158046 |
|
NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:115,313,401...115,359,640
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
multiple interactions |
ISO |
Silybin results in increased expression of and results in increased activity of MGMT protein |
CTD |
PMID:16950796 |
|
NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
multiple interactions |
ISO |
[Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP14 mRNA; Arsenic Trioxide inhibits the reaction [Silybin results in increased expression of MMP14 mRNA] |
CTD |
PMID:21969006 |
|
NCBI chr15:27,887,795...27,897,020
Ensembl chr15:27,887,727...27,899,864
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
increases expression multiple interactions |
ISO EXP |
Silybin results in increased expression of MMP2 mRNA [Silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of MMP2 mRNA] [Arsenic Trioxide co-treated with Silybin] results in decreased activity of MMP2 protein; [Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP2 mRNA; [Silybin co-treated with Arsenic] results in decreased expression of MMP2; Silybin promotes the reaction [Arsenic Trioxide results in decreased expression of MMP2 mRNA] |
CTD |
PMID:16169303 PMID:21969006 PMID:25868784 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression multiple interactions decreases activity |
ISO |
Silybin results in decreased expression of MMP9 mRNA [Arsenic Trioxide co-treated with Silybin] results in decreased expression of MMP9 mRNA; [Silybin co-treated with Arsenic Trioxide] results in decreased activity of MMP9 protein Silybin results in decreased activity of MMP9 protein |
CTD |
PMID:21969006 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
Silybin results in decreased expression of MYC protein |
CTD |
PMID:27746612 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Nat2 |
N-acetyltransferase 2 |
multiple interactions |
EXP |
Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of NAT2 mRNA] |
CTD |
PMID:28619387 |
|
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Ncoa4 |
nuclear receptor coactivator 4 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in increased expression of NCOA4 mRNA]; Silybin inhibits the reaction [Ethanol results in increased expression of NCOA4 mRNA] |
CTD |
PMID:35595033 |
|
NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
Silybin inhibits the reaction [sodium arsenite results in decreased expression of NFE2L2] |
CTD |
PMID:24062023 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
decreases expression |
ISO |
Silybin results in decreased expression of NOS2 protein |
CTD |
PMID:16788158 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
EXP |
Silybin inhibits the reaction [sodium arsenite results in increased expression of NOX4] |
CTD |
PMID:24062023 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression multiple interactions |
IEP ISO |
Silymarin decreases Nqo1 mRNA in liver Silybin inhibits the reaction [cyfluthrin results in decreased activity of NQO1 protein] |
CTD RGD |
PMID:31330490 PMID:31432116 |
RGD:25823187 |
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
increases expression |
EXP |
silymarin increases Nr1h4 mRNA expression in rat kidney and liver |
RGD |
PMID:30308196 |
RGD:15042865 |
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases expression |
ISO |
Silybin results in increased expression of NR1I2 mRNA |
CTD |
PMID:29933105 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Opa1 |
OPA1, mitochondrial dynamin like GTPase |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in decreased expression of OPA1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of OPA1 protein] |
CTD |
PMID:35158046 |
|
NCBI chr11:71,108,100...71,185,170
Ensembl chr11:71,109,873...71,185,109
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO |
Silybin results in increased cleavage of PARP1 protein benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [Silybin results in increased cleavage of PARP1 protein]; GDF15 mutant form inhibits the reaction [Silybin results in increased cleavage of PARP1 protein]; pifithrin inhibits the reaction [Silybin results in increased cleavage of PARP1 protein]; Silybin inhibits the reaction [Acetaldehyde results in increased cleavage of PARP1 protein]; Silybin inhibits the reaction [Ethanol results in increased cleavage of PARP1 protein]; Silybin inhibits the reaction [Staurosporine promotes the reaction [Acetaldehyde results in increased cleavage of PARP1 protein]]; Silybin results in increased cleavage of and results in increased activity of PARP1 protein |
CTD |
PMID:16777994 PMID:24440808 PMID:35158046 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
decreases expression |
ISO |
Silybin results in decreased expression of PCNA protein |
CTD |
PMID:16788158 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pecam1 |
platelet and endothelial cell adhesion molecule 1 |
decreases expression |
ISO |
Silybin results in decreased expression of PECAM1 protein |
CTD |
PMID:16788158 |
|
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
|
|
G |
Pink1 |
PTEN induced kinase 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PINK1 protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 mRNA]; Silybin inhibits the reaction [Ethanol results in decreased expression of PINK1 protein] |
CTD |
PMID:35595033 |
|
NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:150,530,523...150,542,635
|
|
G |
Plau |
plasminogen activator, urokinase |
multiple interactions decreases expression |
ISO |
[Silybin co-treated with Arsenic Trioxide] results in decreased expression of PLAU mRNA; Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of PLAU mRNA]; Silybin promotes the reaction [Arsenic Trioxide results in decreased expression of PLAU mRNA] |
CTD |
PMID:21969006 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
Silybin inhibits the reaction [[Zidovudine co-treated with Isoniazid] results in decreased expression of POR mRNA] |
CTD |
PMID:28619387 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions increases expression |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein] Silybin results in increased expression of PPARG protein |
CTD |
PMID:25559859 PMID:27746612 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PRKN mRNA]; Silybin inhibits the reaction [Acetaldehyde results in decreased expression of PRKN protein]; Silybin inhibits the reaction [Ethanol results in decreased expression of PRKN mRNA]; Silybin inhibits the reaction [Ethanol results in decreased expression of PRKN protein] |
CTD |
PMID:35595033 |
|
NCBI chr 1:48,688,651...49,882,520
Ensembl chr 1:48,690,556...49,882,555
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
decreases expression |
ISO |
Silybin results in decreased expression of PTGS2 protein |
CTD |
PMID:16788158 |
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased phosphorylation of RB1 protein] |
CTD |
PMID:25559859 |
|
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
ISO |
Silybin inhibits the reaction [SLC16A1 protein results in increased uptake of Benzoic Acid] |
CTD |
PMID:17976262 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
Silybin inhibits the reaction [INS1 protein affects the localization of SLC2A4 protein] |
CTD |
PMID:18591783 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions decreases response to substance |
ISO |
fatostatin promotes the reaction [Silybin results in decreased cleavage of SREBF1 protein]; Silybin results in decreased cleavage of and results in increased phosphorylation of SREBF1 protein SREBF1 protein results in decreased susceptibility to Silybin |
CTD |
PMID:25294820 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Tfrc |
transferrin receptor |
multiple interactions |
ISO |
Silybin inhibits the reaction [Acetaldehyde results in increased expression of TFRC protein]; Silybin inhibits the reaction [Ethanol results in increased expression of TFRC protein] |
CTD |
PMID:35595033 |
|
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
[Silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA] |
CTD |
PMID:16169303 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
EXP |
[Silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of TIMP1 mRNA] |
CTD |
PMID:16169303 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
Silybin inhibits the reaction [[Isoniazid co-treated with Zidovudine] results in increased expression of TNF protein] |
CTD |
PMID:28619387 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions affects localization increases phosphorylation increases expression |
ISO |
Caffeine inhibits the reaction [Silybin results in increased phosphorylation of TP53 protein]; pifithrin inhibits the reaction [Silybin results in increased phosphorylation of TP53 protein]; Silybin inhibits the reaction [Mitomycin results in increased expression of TP53] Silybin affects the localization of TP53 protein Silybin results in increased expression of TP53 protein |
CTD |
PMID:16777994 PMID:19834285 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
decreases activity multiple interactions |
EXP ISO |
Silybin metabolite results in decreased activity of UGT1A1 protein Silybin inhibits the reaction [UGT1A1 protein results in increased glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin] |
CTD |
PMID:15155549 PMID:15921999 |
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
decreases activity multiple interactions |
EXP ISO |
Silybin metabolite results in decreased activity of UGT1A6 protein Silybin inhibits the reaction [UGT1A6 protein results in increased glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin] |
CTD |
PMID:15155549 PMID:15921999 |
|
NCBI chr 9:88,747,229...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
multiple interactions |
ISO |
Silybin inhibits the reaction [UGT1A9 protein results in increased glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin] |
CTD |
PMID:15155549 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt2b7 |
UDP glucuronosyltransferase family 2 member B7 |
multiple interactions |
ISO |
Silybin inhibits the reaction [UGT2B7 protein results in increased glucuronidation of 7-hydroxy-4-trifluoromethylcoumarin] |
CTD |
PMID:15155549 |
|
NCBI chr14:20,896,682...20,919,604
Ensembl chr14:20,896,682...20,919,604
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions decreases expression |
ISO |
Silybin promotes the reaction [Lipids deficiency inhibits the reaction [Oxygen deficiency results in increased expression of VEGFA protein]]; Silybin promotes the reaction [Lipids deficiency results in decreased expression of VEGFA protein] Silybin results in decreased expression of VEGFA protein Silybin inhibits the reaction [Urethane results in increased secretion of VEGFA protein] |
CTD |
PMID:16788158 PMID:26087400 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
multiple interactions |
ISO |
[Silybin co-treated with Arsenic] results in decreased expression of VIM |
CTD |
PMID:25868784 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|